All News
Why Would Hand OA Be Less Severe in Black People?
Osteoarthritis (OA) of the hand was less severe according to objective and pain-related markers in Black patients versus those of other racial/ethnic groups after adjustment for known risk factors, researchers found.
Read ArticleLinks:
Dr. John Cush RheumNow ( View Tweet)
Links:
X-Linked Hypophophatemia - Survey Results
The July 2021 RheumNow “Live Vote” surveyed US and non-US rheumatologists on their knowledge and practices when dealing with the bone disorder, X-linked hypophosphatemia (XLH).
Read ArticleLinks:
Fracture Risk with Osteoporosis Drug Holidays
While bisphosphonate drug holidays are recommended, there are few comparative studies.
Read ArticleBest of 2021: Jack of All Subspecialties
It's great to be a rheumatologist, but boy, it's getting harder and harder. You have to be a jack of all trades. You have to be good at cardiovascular disease, osteoporosis, vaccination, inflammatory bowel disease - it just never ends. This and more, as Dr. Cush summarizes more than a dozen journal articles, news reports and questions + cases.
Read ArticleBest of 2021: Tofacitinib Safety Concerns
Dr. Jack Cush reviews and discusses the news and journal reports from the past week on RheumNow.com.
Read ArticleBest of 2021: EULAR Guidelines on Intraarticular Therapy
EULAR has published evidence-based recommendations on the use of intra-articular therapies (IAT) based on the literature review and recommendations of a multidisciplinary international task force. These IAT recommendations apply to adult patients with peripheral arthropathies.
Read ArticleLinks:
Dr. John Cush RheumNow ( View Tweet)
Links:
Links:
Links:
Platelet-Rich Plasma Injections Fail in Ankle Osteoarthritis
A controlled trial of intra-articular platelet-rich plasma (PRP) injections into the ankle of osteoarthritis (OA) patients failed to improve ankle symptoms and function when compared to placebo injections - yet another trial showing that intraarticular injections are seldom beneficial.
Read ArticleLinks:
Dr. John Cush RheumNow ( View Tweet)